Matches in Nanopublications for { ?s ?p "[To address disease heterogeneity in RA FLS cells, we examined the effects of clinical disease parameters (Health Assessment Questionnaire (HAQ) score, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), rheumatoid factor (RF)) and drug therapies (methotrexate/prednisone) on RA FLS cell gene expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP250961.RAXYnSAbeTWwToWAidsCtHGcxp7yUo1-sSE9-k3iHK9H4130_assertion description "[To address disease heterogeneity in RA FLS cells, we examined the effects of clinical disease parameters (Health Assessment Questionnaire (HAQ) score, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), rheumatoid factor (RF)) and drug therapies (methotrexate/prednisone) on RA FLS cell gene expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP250961.RAXYnSAbeTWwToWAidsCtHGcxp7yUo1-sSE9-k3iHK9H4130_provenance.
- assertion description "[To address disease heterogeneity in RA FLS cells, we examined the effects of clinical disease parameters (Health Assessment Questionnaire (HAQ) score, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), rheumatoid factor (RF)) and drug therapies (methotrexate/prednisone) on RA FLS cell gene expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP615218.RAYunIfwGSiu8WVRcYfbhL7tIh0XZHm060Ip7gJJKXSEw130_assertion description "[To address disease heterogeneity in RA FLS cells, we examined the effects of clinical disease parameters (Health Assessment Questionnaire (HAQ) score, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), rheumatoid factor (RF)) and drug therapies (methotrexate/prednisone) on RA FLS cell gene expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615218.RAYunIfwGSiu8WVRcYfbhL7tIh0XZHm060Ip7gJJKXSEw130_provenance.